Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  guadecitabine
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: SGI-110-04, NCI-2015-00230, NCT02348489
Guadecitabine and Irinotecan Hydrochloride or Regorafenib or TAS-102 Alone in Treating Patients with Previously Treated Metastatic Colorectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NA_00085870, J1369, NCI-2013-02005, CIR00004735, CIR00013885, CIR0002117, NA_00085870, NCT01896856
Guadecitabine in Treating Patients with Higher-Risk Myelodysplastic Syndromes
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0901, NCI-2014-02377, NCT02131597
DNA Methyltransferase Inhibitor SGI-110, Donor GVAX and Cyclophosphamide in Treating Patients with Metastatic Colorectal Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13138, NA_00087578, NCI-2014-00919, J13138, NA_00087578, NA_00087578 / CIR00007809, NA_00087578 / CIR00009915, NCT01966289
Start Over